142 related articles for article (PubMed ID: 19850993)
41. Management of breast carcinoma identified intraoperatively during reduction mammaplasty.
Butler CE; Hunt KK; Singletary SE
Ann Plast Surg; 2003 Feb; 50(2):193-7. PubMed ID: 12567059
[TBL] [Abstract][Full Text] [Related]
42. Prospective matched-pair comparison of outcome after treatment for lobular and ductal breast carcinoma.
Mhuircheartaigh JN; Curran C; Hennessy E; Kerin MJ
Br J Surg; 2008 Jul; 95(7):827-33. PubMed ID: 18498127
[TBL] [Abstract][Full Text] [Related]
43. Is routine sentinel lymph node biopsy indicated in women undergoing contralateral prophylactic mastectomy? Magee-Womens Hospital experience.
Soran A; Falk J; Bonaventura M; Keenan D; Ahrendt G; Johnson R
Ann Surg Oncol; 2007 Feb; 14(2):646-51. PubMed ID: 17122987
[TBL] [Abstract][Full Text] [Related]
44. Is lobular carcinoma in situ as a component of breast carcinoma a risk factor for local failure after breast-conserving therapy? Results of a matched pair analysis.
Ben-David MA; Kleer CG; Paramagul C; Griffith KA; Pierce LJ
Cancer; 2006 Jan; 106(1):28-34. PubMed ID: 16329136
[TBL] [Abstract][Full Text] [Related]
45. Sentinel lymph node biopsy in breast cancer patients after neoadjuvant chemotherapy.
Reitsamer R; Peintinger F; Rettenbacher L; Prokop E
J Surg Oncol; 2003 Oct; 84(2):63-7. PubMed ID: 14502778
[TBL] [Abstract][Full Text] [Related]
46. Role of sentinel lymph node biopsy in ductal carcinoma-in-situ treated by mastectomy.
Tan JC; McCready DR; Easson AM; Leong WL
Ann Surg Oncol; 2007 Feb; 14(2):638-45. PubMed ID: 17103256
[TBL] [Abstract][Full Text] [Related]
47. Predictors of nonsentinel node metastasis in patients with breast cancer after sentinel node metastasis.
Joseph KA; El-Tamer M; Komenaka I; Troxel A; Ditkoff BA; Schnabel F
Arch Surg; 2004 Jun; 139(6):648-51. PubMed ID: 15197092
[TBL] [Abstract][Full Text] [Related]
48. Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy.
Kim KJ; Huh SJ; Yang JH; Park W; Nam SJ; Kim JH; Lee JH; Kang SS; Lee JE; Kang MK; Park YJ; Nam HR
Jpn J Clin Oncol; 2005 Mar; 35(3):126-33. PubMed ID: 15741302
[TBL] [Abstract][Full Text] [Related]
49. Changes in management techniques and patterns of disease recurrence over time in patients with breast carcinoma treated with breast-conserving therapy at a single institution.
Pass H; Vicini FA; Kestin LL; Goldstein NS; Decker D; Pettinga J; Ingold J; Benitez P; Neumann K; Rebner M; Dekhne N; Martinez A
Cancer; 2004 Aug; 101(4):713-20. PubMed ID: 15305400
[TBL] [Abstract][Full Text] [Related]
50. Breast cancer in elderly women.
Djordjevic N; Karanikolic A; Pesic M
Arch Gerontol Geriatr; 2004; 39(3):291-9. PubMed ID: 15381348
[TBL] [Abstract][Full Text] [Related]
51. Association of clinical and pathologic variables with lumpectomy surgical margin status after preoperative diagnosis or excisional biopsy of invasive breast cancer.
Smitt MC; Horst K
Ann Surg Oncol; 2007 Mar; 14(3):1040-4. PubMed ID: 17203329
[TBL] [Abstract][Full Text] [Related]
52. Lymph node axillary metastasis from occult contralateral infiltrating lobular carcinoma arising in accessory breast: MRI diagnosis.
Capobianco G; Spaliviero B; Dessole S; Rocca PC; Cherchi PL; Ambrosini G; Meloni F; Meloni GB
Breast J; 2007; 13(3):305-7. PubMed ID: 17461909
[TBL] [Abstract][Full Text] [Related]
53. Adequacy of diagnostic tests and surgical management of symptomatic invasive lobular carcinoma of the breast.
Hadjiminas DJ; Zacharioudakis KE; Tasoulis MK; Hu JC; Lanitis S; Bright-Thomas R; Dimopoulos NG; Hornzee G; Cunningham DA; Cleator SJ; Al Mufti R
Ann R Coll Surg Engl; 2015 Nov; 97(8):578-83. PubMed ID: 26492903
[TBL] [Abstract][Full Text] [Related]
54. Pleomorphic lobular carcinoma with lipid-producing activity: a report of 2 cases.
Okamura T; Tang XY; Saito Y; Suzuki Y; Masuda S; Tokuda Y
Tokai J Exp Clin Med; 2013 Sep; 38(3):103-8. PubMed ID: 24030486
[TBL] [Abstract][Full Text] [Related]
55. The diagnostic utility of the minimal carcinoma triple stain in breast carcinomas.
Ross DS; Liu YF; Pipa J; Shin SJ
Am J Clin Pathol; 2013 Jan; 139(1):62-70. PubMed ID: 23270900
[TBL] [Abstract][Full Text] [Related]
56. Distinct clinical and prognostic features of invasive lobular breast cancer.
Petrausch U; Pestalozzi BC
Breast Dis; 2008-2009; 30():39-44. PubMed ID: 19850994
[No Abstract] [Full Text] [Related]
57. Invasive lobular carcinoma in an axillary breast.
Christey GR; Civil ID
Aust N Z J Surg; 1998 Apr; 68(4):305-6. PubMed ID: 9572347
[No Abstract] [Full Text] [Related]
58. [Breast MRI in invasive lobular carcinoma: diagnosis and staging].
Fabre Demard N; Boulet P; Prat X; Charra L; Lesnik A; Taourel P
J Radiol; 2005 Sep; 86(9 Pt 1):1027-34. PubMed ID: 16224343
[TBL] [Abstract][Full Text] [Related]
59. Diagnosis of invasive lobular carcinoma in a young woman presenting with pleomorphic lobular carcinoma in situ on core biopsy.
Kounalakis N; Diamond J; Rusthoven K; Horn W; Jindal S; Wisell J; Klein CE; Elias A; Finlayson C; Borges VF
Oncology (Williston Park); 2011 Apr; 25(4):351-6. PubMed ID: 21618957
[No Abstract] [Full Text] [Related]
60. Reproducibility of a diagnosis of invasive lobular carcinoma.
Cserni G
J Surg Oncol; 1999 Apr; 70(4):217-21. PubMed ID: 10219016
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
